dcsimg

Ministry of Health, National Committee for the Control of Viral Hepatitis celebrate Egypt's first and world's largest hepatitis C patient registry

Under the auspices of the Ministry of Health, the National Committee for the Control of Viral Hepatitis held a press conference at the National Liver Institute to officially launch Egypt's first national hepatitis C patient registry. Linking interferon treatment centers across the country, the national network is considered the world's largest database for hepatitis C patients.

"The hepatitis C patient registry marks a new era toward controlling the disease in Egypt. It centralizes records for patients receiving treatment via liver centers nationwide; to date it includes the records of over 32,000 patients," said Dr Wahid Doss, Dean of the National Liver Institute. "This project will transform hepatitis C treatment in Egypt by effectively managing resources to achieve the highest cure rates, closely monitoring patient progress and following up on the number of injections dispensed which strongly supports patient compliance."

"I would like to extend my deep appreciation for Hoffmann La Roche's support, not only on this project but for its ongoing support of all efforts towards tackling hepatitis C in Egypt. I would also like to thank the Academy of Scientific Research and Technology for its tremendous efforts that have truly enabled this project's success," he said.

Dr Wafaa Al Akel, Executive Manager of the HCV Patient Registry said, "The Network helps assess the actual extent of various issues associated with HCV infection. It shows the number of patients applying for treatment thereby helping deliver quality patient care, and the most common means of transmission so we can prevent infection at its root."

"Roche is immensely proud to be here today to celebrate the success of Egypt's first HCV patient registry," said Dr Ehab Youssef, General Manager, Hoffman La Roche Egypt. "We would like to express our gratitude to the Health Ministry and the National Committee for allowing us the privilege of supporting this vital project. Roche is extremely keen on demonstrating its commitment to the community; we will continue to provide hepatitis C treatment to Egypt's government institutions at the lowest price worldwide, support the establishment of treatment units and take part in awareness initiatives to curb HCV in Egypt."

The National Committee launched the National Project for hepatitis C treatment in 2006. To date, more than 240,000 patients have been treated at the state's expense via 23 nationwide liver centers. The Ministry of Health has so far spent LE2 billion to support the project and succeeded, in cooperation with manufacturing companies, in providing globally approved treatments at the lowest cost worldwide substantially alleviating the economic burden.
Leading Swiss Pharmaceutical Roche recognized as Main Sponsor.
Leading Swiss Pharmaceutical Roche recognized as Main Sponsor.
Enlarge »
Article Options
Log in to request more information from Egyptian Ministry of Health

Notes and Media Contacts »

Please Login or Register to view notes and media contacts information

Disclaimer »

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / 4C. AME Info FZ LLC / 4C is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions